Nanobiotix SA
PAR:NANO

Watchlist Manager

Nanobiotix SA

PAR:NANO

Watchlist

Dividends

Price: 3.954 EUR 0.61% Market Closed

Market Cap: 186.3m EUR

Have any thoughts about
Nanobiotix SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 3.954 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

NANO Alert

Nanobiotix SA

3.954

+0.024 (+0.61%)

52 Week Range	3.874 7.54
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Nanobiotix SA

What unique competitive advantages
does Nanobiotix SA hold over its rivals?

What risks and challenges
does Nanobiotix SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Nanobiotix SA.

What unique competitive advantages
does Nanobiotix SA hold over its rivals?

What risks and challenges
does Nanobiotix SA face in the near future?

Summarize the latest earnings call
of Nanobiotix SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Nanobiotix SA.

Provide P/S
for Nanobiotix SA.

Provide P/E
for Nanobiotix SA.

Provide P/OCF
for Nanobiotix SA.

Provide P/FCFE
for Nanobiotix SA.

Provide P/B
for Nanobiotix SA.

Provide EV/S
for Nanobiotix SA.

Provide EV/GP
for Nanobiotix SA.

Provide EV/EBITDA
for Nanobiotix SA.

Provide EV/EBIT
for Nanobiotix SA.

Provide EV/OCF
for Nanobiotix SA.

Provide EV/FCFF
for Nanobiotix SA.

Provide EV/IC
for Nanobiotix SA.

Show me price targets
for Nanobiotix SA made by professional analysts.

What are the Revenue projections
for Nanobiotix SA?

How accurate were the past Revenue estimates
for Nanobiotix SA?

What are the Net Income projections
for Nanobiotix SA?

How accurate were the past Net Income estimates
for Nanobiotix SA?

What are the EPS projections
for Nanobiotix SA?

How accurate were the past EPS estimates
for Nanobiotix SA?

What are the EBIT projections
for Nanobiotix SA?

How accurate were the past EBIT estimates
for Nanobiotix SA?

Compare the revenue forecasts
for Nanobiotix SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Nanobiotix SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nanobiotix SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nanobiotix SA compared to its peers.

Compare the P/E ratios
of Nanobiotix SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Nanobiotix SA with its peers.

Analyze the financial leverage
of Nanobiotix SA compared to its main competitors.

Show all profitability ratios
for Nanobiotix SA.

Provide ROE
for Nanobiotix SA.

Provide ROA
for Nanobiotix SA.

Provide ROIC
for Nanobiotix SA.

Provide ROCE
for Nanobiotix SA.

Provide Gross Margin
for Nanobiotix SA.

Provide Operating Margin
for Nanobiotix SA.

Provide Net Margin
for Nanobiotix SA.

Provide FCF Margin
for Nanobiotix SA.

Show all solvency ratios
for Nanobiotix SA.

Provide D/E Ratio
for Nanobiotix SA.

Provide D/A Ratio
for Nanobiotix SA.

Provide Interest Coverage Ratio
for Nanobiotix SA.

Provide Altman Z-Score Ratio
for Nanobiotix SA.

Provide Quick Ratio
for Nanobiotix SA.

Provide Current Ratio
for Nanobiotix SA.

Provide Cash Ratio
for Nanobiotix SA.

What is the historical Revenue growth
over the last 5 years for Nanobiotix SA?

What is the historical Net Income growth
over the last 5 years for Nanobiotix SA?

What is the current Free Cash Flow
of Nanobiotix SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Nanobiotix SA.

EV/EBITDA
Enterprise Value to EBITDA

-6.6

Current

-4.4

Median

4.3

Industry

Lower than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

-6.6

Enterprise Value

154.7m EUR

EBITDA

-23.5m EUR

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
FR		Nanobiotix SA PAR:NANO	186.3m EUR	-6.6
FR		Pharnext SCA OTC:PNEXF	6T USD	-213 636.5
US		Abbvie Inc NYSE:ABBV	352.5B USD	17
US		Amgen Inc NASDAQ:AMGN	174.8B USD	18.9
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	133.2B USD	28.2
US		Gilead Sciences Inc NASDAQ:GILD	120.3B USD	10.6
US	E	Epizyme Inc F:EPE	94.1B EUR	-528.9
AU		CSL Ltd ASX:CSL	137.9B AUD	21.1
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	91.2B USD	18
US	S	Seagen Inc F:SGT	39.3B EUR	-60.4
NL		argenx SE XBRU:ARGX	33.2B EUR	-103.1

				EBITDA Growth
FR		Nanobiotix SA PAR:NANO	Average EV/EBITDA: 19 Negative Multiple: -6.6	N/A
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -213 636.5	N/A
US		Abbvie Inc NYSE:ABBV	17	28%
US		Amgen Inc NASDAQ:AMGN	18.9	63%
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	28.2	38%
US		Gilead Sciences Inc NASDAQ:GILD	10.6	12%
US	E	Epizyme Inc F:EPE	Negative Multiple: -528.9	N/A
AU		CSL Ltd ASX:CSL	21.1	42%
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	18	46%
US	S	Seagen Inc F:SGT	Negative Multiple: -60.4	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -103.1	N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

-3.4

2-Years Forward

EV/EBITDA

-3

3-Years Forward

EV/EBITDA

-6.1

Nanobiotix SA
PAR:NANO

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Nanobiotix SA PAR:NANO

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Nanobiotix SA
PAR:NANO

EV/EBITDA
Enterprise Value to EBITDA